pharmaco-metabonomic phenotyping personalized drug treatment 
clear case drug treatments selected according characteristics individual patient order improve efficacy reduce number severity adverse drug reactions12 however personalization drug treatments requires ability predict different individuals will respond particular drug/dose combination initial optimism increasing recognition limitations pharmacogenomic approach take account important environmental influences drug absorption distribution metabolism excretion3- instance major factor underlying inter-individual variation drug effects variation metabolic phenotype influenced genotype also environmental factors nutritional status gut microbiota age disease co pre-administration drugs67 thus although genetic variation clearly important seems unlikely personalized drug therapy will enabled wide range major diseases using genomic knowledge alone describe alternative conceptually new pharmaco-metabonomic approach personalizing drug treatment uses combination pre-dose metabolite profiling chemometrics model predict responses individual subjects provide proof-of-principle new approach sensitive genetic environmental influences study paracetamol acetaminophen administered rats show pre-dose prediction aspect urinary drug metabolite profile association pre-dose urinary composition extent liver damage sustained paracetamol administration 
